USB-PH(USB-PH)
USB-PH
Q4 2026 EPS Estimate
$1.30
Oct 15, 2026 · Reports before open
Revenue Estimate
$7.96B
FY2026E EPS$5.22
FY2027E EPS$5.82
Analyst Sentiment
Wall St. Consensus
Buy24 analysts·High coverage
64
Score
13 Buy (54%)11 Hold (46%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1354%
Hold
1146%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$47.00
+157.9%
Consensus
$55.00
+201.8%
Bull
$60.00
+229.2%
12-Month Target Range24 analysts
$47.00$55.00$60.00
Current $18.23Consensus
Current Price
$18.23
Upside to Consensus
$36.77
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+6.64%
EPS+11.54%
FY2028
Rev+5.72%
EPS+10.46%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $30.96B | $33.02B | $34.91B |
| Low | $30.83B | $32.74B | $34.68B |
| High | $31.01B | $33.25B | $35.06B |
| EBITDA Avg | $8.53B | $9.10B | $9.62B |
| Low | $8.50B | $9.02B | $9.56B |
| High | $8.55B | $9.16B | $9.66B |
| EBIT Avg | $7.87B | $8.40B | $8.88B |
| Low | $7.84B | $8.33B | $8.82B |
| High | $7.89B | $8.46B | $8.92B |
| Net Income Avg | $8.13B | $9.07B | $10.02B |
| Low | $8.07B | $9.00B | $9.94B |
| High | $8.18B | $9.12B | $10.08B |
| EPS Avg | $5.22 | $5.82 | $6.43 |
| Low | $5.18 | $5.77 | $6.38 |
| High | $5.25 | $5.86 | $6.47 |
| Analysts (Rev / EPS) | 9 / 1 | 12 / 1 | 5 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $7.96B | $8.06B | $7.99B | $8.27B | $8.41B | $8.49B | $8.55B | $8.78B |
| Low | $7.93B | $7.95B | $7.93B | $8.21B | $8.34B | $8.42B | $8.48B | $8.71B |
| High | $7.98B | $8.10B | $8.03B | $8.31B | $8.44B | $8.53B | $8.59B | $8.82B |
| EBITDA Avg | $2.19B | $2.22B | $2.20B | $2.28B | $2.32B | $2.34B | $2.36B | $2.42B |
| Low | $2.19B | $2.19B | $2.18B | $2.26B | $2.30B | $2.32B | $2.34B | $2.40B |
| High | $2.20B | $2.23B | $2.21B | $2.29B | $2.33B | $2.35B | $2.37B | $2.43B |
| EBIT Avg | $2.02B | $2.05B | $2.03B | $2.10B | $2.14B | $2.16B | $2.17B | $2.23B |
| Low | $2.02B | $2.02B | $2.02B | $2.09B | $2.12B | $2.14B | $2.16B | $2.21B |
| High | $2.03B | $2.06B | $2.04B | $2.11B | $2.15B | $2.17B | $2.18B | $2.24B |
| Net Income Avg | $2.02B | $2.15B | $2.03B | $2.25B | $2.33B | $2.38B | $2.23B | $2.47B |
| Low | $2.00B | $2.13B | $2.01B | $2.23B | $2.31B | $2.36B | $2.21B | $2.44B |
| High | $2.04B | $2.16B | $2.04B | $2.26B | $2.35B | $2.39B | $2.25B | $2.48B |
| EPS Avg | $1.30 | $1.38 | $1.31 | $1.45 | $1.50 | $1.53 | $1.44 | $1.59 |
| Low | $1.29 | $1.37 | $1.29 | $1.43 | $1.48 | $1.52 | $1.42 | $1.57 |
| High | $1.31 | $1.39 | $1.31 | $1.45 | $1.51 | $1.54 | $1.44 | $1.60 |
| Analysts (Rev / EPS) | 10 / 1 | 10 / 1 | 9 / 1 | 9 / 1 | 9 / 1 | 9 / 1 | 8 / 1 | 8 / 1 |